From common to unreported: a real-world study of adverse events to duloxetine in the treatment of osteoarthritis
Our study contributes to an in-depth understanding of the safety of duloxetine in the treatment of osteoarthritis.
Authors
- Jingkai Di (ORCID: https://orcid.org/0000-0002-2814-9400)
- Chuan Xiang (ORCID: https://orcid.org/0000-0002-1121-6443)
- Yaru Liu (ORCID: https://orcid.org/0000-0002-8530-2547)
- Lujia Liu (ORCID: https://orcid.org/0000-0001-6744-5459)
- Xinglong Xing
- Likun Qi
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1080/14740338.2024.2393470
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00